大肠癌术前肠镜检查与术后结果的临床分析

目的 :探讨大肠癌肠镜检查结果与手术治疗结果的关系。方法 :分析 45例大肠癌的临床资料、大肠镜检查结果及手术治疗情况。结果 :直肠癌检出率最高 ,青年人大肠癌发病率在逐渐上升 ;直肠癌肛门指检阳性率为73.3% ,大肠镜诊断大肠癌的准确率为 10 0 %。结论 :根据大肠镜检查的结果可判断大肠癌的部位、病理分类、范围和程度 ,但其不能作为选择手术方式的依据     

早期胃癌的诊治(附15例临床分析)

目的：总结15例早期胃癌临床特点，诊治经验，探讨治疗新进展。方法：对15例早期胃癌诊治进行回顾性总结。结果：早期误诊率达66．7％，15例手术，术后存活5年以上13例（86．7％）。结论：早期胃癌缺乏特异症状，早期误诊率高，内镜下平坦型胃癌最易误诊，作认为D2术应为根治EGC的标准术式，内镜下粘膜切除术（EMR），保留迷走神经胃段切除术有利于保护患术后生存质量。     

原癌基因蛋白质C-erbB-2在乳腺良恶性病变中表达的意义

目的:检测原癌基因蛋白质C-erbB-2在乳腺良恶性病变中的表达及意义.方法:对111例乳腺良恶性病变的石蜡切片标本进行免疫组织化学染色.结果:乳腺良恶性病变中乳腺导管内乳头状瘤病的C-erbB-2阳性率为31.3%,与乳腺纤维腺病和纤维腺瘤比较差异有显著性(P<0.01),乳腺癌C-erbB-2的阳性率为74.3%,与良性病变比较差异有显著性(P<0.01);乳腺癌C-erbB-2表达与肿瘤大小和组织学分级呈正比(P<0.05),与激素受体(ER、PR)水平及5年生存期呈反比(P<0.05),与淋巴结是否转移无关.结论:C-erbB-2表达的乳腺导管内乳头状瘤病容易癌变,C-erbB-2过度表达的乳腺癌组织分化差、生存期短、预后不好.C-erbB-2 可作为判定乳腺导管内乳头状瘤病早期癌变及乳腺癌预后的有效指标.     

Relationship with God and the Quality of Life of Prostate Cancer Survivors

This study explored the role of relationship with God with respect to the quality of life of men with prostate cancer. Thirty-four men with prostate cancer completed questionnaires on demographic and illness factors, aspects of relationship with God (e.g., God image), nonreligious resources (e.g., optimism) and physical, social and emotion functioning. Results showed that relationship with God was a significant factor in the prediction of role, emotional and social functioning for these men after controlling for age, reported severity of treatment reactions and nonreligious resources. Notably, different aspects of relationship with God (e.g., causal attribution) evidenced different associations with functioning and the nonreligious resource of perceived health control. Such results suggest that relationship with God may function in a complex manner as a resource in coping with prostate cancer. Longitudinal research is needed to clarify the role of religious/spiritual resources in the short- and long-term quality of life of men with prostate cancer.     

Evaluation of an aortic stent graft for use in surgery on esophageal cancer involving the thoracic aorta

Objective: The purpose of this experimental study was to investigate whether aortic stent grafting can be applied to the treatment of an esophageal cancer involving the thoracic aorta. Methods: The canine thoracic aorta was partially resected without aorta being clamped after emplacement of an endovascular stent graft. Study I; The aortic whole layer of 1 cm in length and 1/4 of the circumference was resected and was covered by a free fascia patch of the abdominal rectal muscle immediately after stent graft placement. Study II; The aortic adventitia and the outer half of the media of the same size was resected on day 3, 7,14, 21, and on day 28, after the stent graft placement. The resected portion was covered by the free fascia patch in half experimental dogs, and was uncovered in the others. Study III; The aortic adventitia and the outer half of the media of 1 cm in length and 1/2 of the circumference was resected and was uncovered on day 7 after stent graft placement. Histological examinations were performed on day 28 and at one year after aortic resection. Results: The aortic wall could be resected in all cases with no complication, except in resection of 1/2 the circumference where the aorta had become narrow. There was no difference in healing of the resected portion of the aorta between with and without fascia covering. Conclusion: An aortic endovascular stent graft could be applied to surgery for an esophageal cancer involving the aorta.     

食管癌颈部吻合术中前壁单层吻合术的应用

目的　探讨食管癌颈部吻合术中前壁单层吻合的临床应用价值 ,并与同期荷包状食管胃吻合法 (前壁双层吻合法 )相比较。方法　对 32 1例食管癌行根治性切除及食管胃颈部吻合术 ,其中前壁双层吻合 16 1例 ,前壁单层吻合16 0例。结果　双层吻合术中 ,吻合口瘘 5例 (3.13% ) ,随访 137例 ,吻合口直径 <0 .5 cm者占 5例 (3.5 % ) ,0 .5 - 1cm者70例 (5 0 .9% ) ,1cm以上者 6 2例 (4 5 .6 % ) ,单层吻合术中 ,吻合口瘘 7例 (4 .38% ) ,随访 131例 ,吻合口直径 <0 .5 cm者无 1例发生 ,0 .5 - 1cm者 5 3例 (4 0 .8% ) ,>1cm以上者 78例 (5 9.2 % )。结论　食管癌颈部吻合术中 ,前壁单层吻合能减少吻合口狭窄 ,改善术后病人的生活质量 ,而吻合口瘘发生率无明显增加。     

非小细胞肺癌微转移灶的检测及临床意义

非小细胞肺癌(NSCLC)是常见的恶性肿瘤，治疗效果不佳，有许多术中证实淋巴结阴性的患者仍在术后出现复发，这可能是由于存在常规病理手段无法发现的微转移病灶所导致。近年来，免疫组化和分子生物学方法已应用于外周血、骨髓及肿瘤附近淋巴结中微转移灶的检测，但是检测微转移灶的指标选择及临床意义目前仍有争论。作者讨论常见的检测NSCLC微转移的方法及检测结果的临床意义。     

经皮穿刺氩氦刀冷冻治疗肝癌56例临床分析

目的　探讨氩氦刀冷冻治疗肝脏恶性肿瘤的临床意义。方法　 2 0 0 1年 7月～ 2 0 0 2年6月 5 6例肝脏恶性肿瘤在B型超声引导下行经皮穿刺氩氦刀冷冻治疗。术后患者定期复查血清肿瘤标记物、B型超声检查及CT或MRI。结果　患者肝功能ChildA级 5 0例 ,ChildB级 5例 ,ChildC级 1例。原发性肝癌 4 6例 ,转移性肝癌 10例。小肝癌 (直径≤ 5cm)甲胎蛋白阳性者治疗后转阴占80 % ,甲胎蛋白阴性者治疗后CT或MRI复查病灶完全坏死达 6 1.5 %。转移性肝癌治疗后瘤标降至正常或CT、MRI提示病灶完全坏死者占 6 0 %。结论　氩氦刀冷冻治疗肝脏恶性肿瘤是一种微创、安全、疗效可靠的新方法。对于不适宜行手术治疗的肝脏恶性肿瘤患者是一种有效的微创外科治疗方法。     

三维适形放射治疗门静脉癌栓23例

目的探讨三维适形放射治疗门脉癌栓的近期疗效.资料与方法 23例均为肝癌介入治疗后出现门静脉癌栓,其中原发性肝癌8例,转移性肝癌15例,所有病人均在介入治疗2～4次后出现门静脉癌栓.采用三维适形照射的方法,每例均设定4～6个非共面野,单次照射剂量3～7Gy,6～15次,每日或隔日照射,总剂量42～48 Gy.结果总有效率3个月为82.6%,6个月为95.7%,Kaplan-Meier分析法,1、2、3年生存率分别为82.6%、43.5%和26.1%,中位生存期14个月.Cox回归分析提示Child-Pugh肝功能分级和单次照射剂量与预后有关.结论三维适形放射治疗肝癌介入后门静脉癌栓是一种方法简单、病人易于接受、近期疗效显著的可行性方法,值得临床推广.